Pestalozzi advises EIB on EUR 25m venture debt with GeNeuro

The European Investment Bank (EIB) and GeNeuro, a French biopharmaceutical company, has entered through its R&D subsidiary, GeNeuro Innovation, into a financing agreement for a total amount of up to EUR 25 million.

The credit facility is divided into three tranches of EUR 7 million, EUR 10 million and EUR 8 million respectively, whereby disbursement of each tranche is subject to fulfilment of certain conditions, amongst others, the grant of warrants to EIB. A warrant agreement has been concuded between GeNeuro and EIB, which complements the financing agreement.

GeNeuro developes novel treatments for neurodegenerative and autoimmune diseases (such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS) and the severe consequences of COVID-19, through its R&D subsidiary based in Lyon.

Pestalozzi has advised EIB on all aspects of Swiss law of this transaction, supporting Gide as lead counsel. The team included partner Franz Schubiger (corporate / m&a, life sciences, pictured left), associate Manu Ferro (financial services, capital markets, pictured right), Urs Kloeti (partner, financial services), partner Nils Harbeke (tax), associate Mercedes Chiabotti (corporate / m&a, capital markets).

Pestalozzi advises EIB on EUR 25m venture debt with GeNeuro


Launched in 2020 by LC Publishing Group, it is the first digital portal addressed to the Swiss legal market.
In terms of contents, the website focuses on both law firms and in-house legal departments, covering the latest news and rumors on deals and operations (and the related advisors) as well as on lateral hires, moves and new appointments and providing insights, analytical data and opinions on the professions’ main trends and topics (Ai, innovation, etc.).

For further information, please visit the Group’s website

LC Publishing Group S.p.A. – Via Tolstoi 10 – 20146 Milano – Tel. 0236727659 – C.F./P.IVA 07619210961
REA 1971432 Registro delle Imprese di Milano – Cap. Soc. Euro 50.000,00 i.v.

Copyright 2023 © All rights Reserved. Design by Origami Creative Studio


Share on linkedin
Share on twitter
Share on facebook
Share on whatsapp
Share on email
Share on telegram